Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study
This article is from
The Cancer Letter
archive.
Vol. 35 No. 5 | May 25, 2012
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Harkin Withdraws Amendment Allow NIH To Bypass INDS
October 9, 1992
TCL Archive
Industry Groups Lobby for Lower Standards for FDA Approval
November 18, 2011
TCL Archive
NCI To Test 5,000 DC-Area Jews To Determine Risk Of BRCA 1 Mutation
October 6, 1995
TCL Archive
Cancer Mortality Increase Of 5.2% Now 28% Or Less
January 30, 1976
TCL Archive
Senators Call Mammography Debate Confusing, Say Screening “Saves Lives”.
March 8, 2002
TCL Archive
Abstracts Of Papers From Therapeutic Radiology Meeting
November 21, 1975